Antidepressants Linked To Blindness
Millions of Americans rely on antidepressants to manage depression, anxiety, and other mental health conditions. For many, these medications are life-changing. But like all powerful pharmaceuticals, they come with side effects. While patients are generally warned about weight gain, nausea, or sleep disturbances, there is a much more severe risk that is often overlooked until it is too late: permanent vision damage.
Over the past decade, a growing body of medical research—and subsequent FDA warnings—has linked a popular class of antidepressants known as SSRIs (Selective Serotonin Reuptake Inhibitors) to serious eye disorders, including accelerated cataract development and a sudden, vision-threatening condition called Acute Angle-Closure Glaucoma.
At Chance, Forlines, Carter & King, PC, our pharmaceutical liability attorneys believe that drug manufacturers have a legal duty to fully warn patients and doctors about the risks of their products. When they fail to do so, patients who lose their vision deserve justice.

How SSRIs and SNRIs Affect the Eyes
To understand why these drugs can damage your vision, you have to understand how they work. SSRIs (like Zoloft, Prozac, and Paxil) and SNRIs (like Effexor) work by increasing the levels of serotonin in the brain.
However, serotonin receptors are not just located in the brain—they are also present in the eyes. When these drugs alter serotonin levels, they can cause the pupil to dilate. In patients with certain anatomical eye structures, this dilation can block the drainage of fluid from the eye, leading to a massive, sudden spike in eye pressure.
The Danger of Acute Angle-Closure Glaucoma (AACG)
This sudden spike in pressure is called Acute Angle-Closure Glaucoma (AACG). Unlike standard glaucoma, which develops slowly over years, AACG is a medical emergency. Symptoms can appear within hours and include:
- Sudden, severe eye pain
- Blurred vision or sudden vision loss
- Seeing “halos” around lights
- Redness in the eye
- Nausea and vomiting accompanying the eye pain
If not treated immediately (often requiring emergency laser surgery), the pressure can permanently damage the optic nerve, resulting in irreversible blindness. Because of this severe risk, the FDA now requires many SSRI and SNRI manufacturers to include warnings about angle-closure glaucoma on their drug labels.
The Link to Cataracts
Beyond glaucoma, extensive epidemiological studies have also linked SSRI use to a significantly higher risk of developing cataracts. A landmark study published in the journal Ophthalmology evaluated over 18,000 patients and found that those taking SSRIs were 15% more likely to develop cataracts requiring surgery.
Certain specific drugs showed an even higher correlation. Patients taking Paxil (paroxetine) were 23% more likely to develop cataracts, while those on Effexor (venlafaxine) faced a 33% higher risk. The study suggested that serotonin receptors in the lens of the eye may react to the medication, causing the lens to become opaque much faster than it would through normal aging.
Which Antidepressants Are Linked to Vision Problems?
While any drug that alters serotonin levels carries some risk, the medical literature and FDA warnings have specifically highlighted several blockbuster medications, including:
- Zoloft (sertraline): The FDA label for Zoloft explicitly warns that the drug can cause angle-closure glaucoma.
- Paxil (paroxetine): Strongly linked to accelerated cataract development.
- Lexapro (escitalopram): Carries FDA warnings regarding eye pressure and glaucoma risks.
- Celexa (citalopram): Linked to pupil dilation and subsequent drainage blockage.
- Effexor (venlafaxine): An SNRI that has shown one of the highest correlations with early-onset cataracts.
Note: You should never stop taking a prescribed antidepressant abruptly without consulting your doctor, as this can cause severe withdrawal symptoms.
Holding Drug Manufacturers Accountable
When a pharmaceutical company brings a drug to market, the law requires them to provide adequate warnings about all known risks. If a manufacturer knew—or should have known—that their antidepressant could cause severe eye damage but failed to warn the public, they can be held strictly liable for the resulting harm.
Many patients who suffered sudden blindness from AACG or required premature cataract surgery were never told by their doctors to get a preventative eye exam before starting an SSRI. Why? Because for years, the drug companies did not prominently disclose the risk.
If you suffered vision loss due to an antidepressant, a product liability lawsuit can help you recover compensation for:
- Medical bills, including emergency eye surgery and ongoing ophthalmology care
- Lost wages if your vision loss prevents you from working
- Pain, suffering, and the emotional toll of losing your sight
- The cost of adaptive equipment and lifestyle modifications
The Statute of Limitations in Georgia
If you intend to file a lawsuit against a drug manufacturer, time is limited. In Georgia, the statute of limitations for product liability and personal injury claims is generally two years from the date you discovered (or reasonably should have discovered) that the drug caused your injury.
Because linking vision loss to a medication can be medically complex, it is critical to speak with an attorney as soon as you suspect a connection.
Frequently Asked Questions
Can antidepressants cause blindness or vision loss?
Yes. Certain antidepressants, particularly SSRIs and SNRIs, have been linked to an increased risk of severe eye disorders. The two most significant risks are the accelerated development of cataracts and Acute Angle-Closure Glaucoma (AACG), which can cause permanent vision loss if not treated immediately.
Which antidepressants carry FDA warnings for eye problems?
The FDA requires warning labels on many popular SSRI and SNRI antidepressants regarding the risk of angle-closure glaucoma. Drugs that carry this warning or have been linked to vision issues in clinical studies include Zoloft, Paxil, Lexapro, Celexa, and Effexor.
Can I sue a drug manufacturer for antidepressant-related vision loss?
If you developed severe vision loss, cataracts requiring surgery, or acute angle-closure glaucoma after taking an SSRI or SNRI, you may have grounds for a product liability lawsuit. This is especially true if the drug lacked adequate warning labels at the time you were prescribed it.
Contact Our Atlanta Defective Drug Lawyers
Losing your vision is a devastating, life-altering event. If your vision loss was caused by a pharmaceutical company’s failure to warn you about the dangers of their antidepressant, you deserve answers—and you deserve justice.
The dangerous drugs and medical devices attorneys at Chance, Forlines, Carter & King, PC have a proven track record of standing up to massive pharmaceutical corporations. We have the resources and medical experts necessary to prove your case.
Call us today at 404-760-7400 or contact us online for a free, confidential case evaluation. We handle all defective drug cases on a contingency fee basis, meaning you pay nothing out of pocket unless we win your case.
PRACTICE AREAS
CASE RESULTS
TESTIMONIALS
"My siblings and I engaged Chance, Forlines, Carter & King, PC during an extremely stressful time in our lives, and we are thankful that they provided a warm working environment. We were highly impressed by their level of knowledge, their efficiency and their extreme professionalism. From our first contact to our very last conversation, we felt that our team at LCFCK genuinely cares about helping people."
V. FORD
READ MORE